India, May 11 -- Dyne Therapeutics, Inc. (DYN) reported Monday that net loss for the first quarter was $120.85 million or $0.73 per share, compared to net loss of $115.36 million or $1.05 per share in the prior-year quarter.
In Thursday's pre-market trading, DYN is trading on the Nasdaq at $17.50, down $0.11 or 0.62 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....